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Introduction
Among sexually active men and women, the human papilloma virus (HPV) is one of
the most common sexually transmitted infections. With more than 200 different
genotypes of HPV known, there are more than 500,000 cases each year in the United
States alone (Lowy, 2016). The virus is associated with nearly all cervical cancers, anal
cancers, vaginal cancers, penile cancers, and head and neck cancers (Jorge & Wright,
2016). In women, the virus is capable of causing slow cellular changes on the cervix,
and this dysplasia is graded based on severity (Jorge & Wright, 2016).
The statistics related to the prevalence and transmission rate of this virus are
staggering, and primary healthcare providers must have a solid knowledge base of the
pathophysiology behind the disease process to better serve their patient population.
This project will examine the pathophysiology associated with the different stages of
cervical dysplasia, and to review the nursing implications in managing this disease
population.

Underlying Pathophysiology
 There are more than 100 types of HPV (Smith & Travis,
2011).
 HPV infects the basal layer of the epithelium, and in these
lesions, the viral HPV DNA is integrated into the human
genome. These oncogenes can manipulate healthy cells
by inducing chromosomal abnormalities and blocking
apoptosis (Jorge & Wright, 2016).
 Most HPV infections are transient, but cytology changes
may persist. The patient will generally not experience
symptoms of the infection (Smith & Travis, 2011).
 High-risk HPV proteins E6 and E7 are responsible for
protein degradation, causing chromosomal instability
and cell proliferation (Orlando et al., 2013).
 E6 and E7 act as mutagens and promote cell division and
delayed cell differentiation, leading to hyperproliferative
lesions (Orlando et al., 2013).
 Early HPV proteins can increase the number of epidermal
growth factor receptors, allowing HPV-infected cells to
ignore antigrowth signals (Orlando et al., 2013).

Significance of Pathophysiology

Figure 1. HPV progression (Crow, 2012)

Transmission, Signs & Symptoms
 The virus is spread by direct skin-to-skin contact of the genitals and other skin
surfaces. Since the virus requires a tissue to tissue interaction, HPV cannot be spread
by touching inanimate surfaces, such as a toilet seat (Smith & Travis, 2011).
 Engaging in high-risk sexual behavior increases the risk of HPV transmission. Highrisk behaviors include inconsistent condom use, multiple sex partners, having a new
partner, or having sex while under the influence of drugs/alcohol (Goyle, Mattocks, &
Sadler, 2012).
 Roughly 6 million new cases of HPV are reported yearly worldwide in both men and
women, with approximately 20 million men and women already infected in the
United States (Smith & Travis, 2011).
 Human papillomavirus has a high infectivity rate with up to a 60% chance of
transmission per sexual contact (Jorge & Wright, 2016).
 The patient will not usually experience symptoms with cervical changes from the
high-risk HPV strains, which is why routine Pap smears are important for
discovering and managing these precancerous lesions (Smith & Travis, 2011).

 HPV types 16 & 18 cause 70% of cervical cancers
(Smith & Travis, 2011).
 Persistent infections have the highest risk for
developing high-grade precancerous lesions or
cervical cancer, and co-infection with more than 1
HPV serotype increases this risk(Smith & Travis,
2011).
 HPV infection cofactor classification (Charlton et
al., 2014):
 Environmental/exogenous factors
(smoking, diet, oral contraceptives)
 Host factors (endogenous hormones,
genetics, immune response)
 Viral factors (HPV type, viral load, viral
integration)
 HPV infection is slow progressing. 15% of
high=grade lesions progress to invasive cervical
cancer in 5-10 years (Jorge & Wright, 2016).

Nursing Considerations
 Vaccination with the HPV Quadrivalent Recombinant
vaccine is standard of care for all females aged 9-26,
but is contraindicated in pregnancy (Smith & Travis,
2011).
 The counseling approach of younger patients and
their parents may be different than that of a sexually
active, more mature population (Sussman et al.,
2015).
 HPV types 16 & 18 are responsible for most cervical
lesions & cancers (Moore et al., 2011).
 HPV DNA testing with cervical cytology is
recommended (Nelson et al., 2104).
 Treatment of persistent HPV: colposcopies, cold
knife conization, and loop electrosurgical excision
procedures (LEEP) (Charlton et al., 2014).
 Excisional procedures cause cervical collagen
remodeling, and this may lead to an increased risk of
preterm birth (Miller et al., 2015).
 Smoking, number of sexual partners, and use of oral
contraceptives are risk factors (Charlton et al.,
2014).

Conclusion
Human papilloma virus is a common virus spread
among sexually active men and women. The
implications for women are HPV infections that may
cause dysplastic changes of the cervix over time.
Nursing care should be geared toward prevention, with
vaccination and Pap smears among the two best
practice modalities. Close monitoring with use of the
most current algorithms should guide the management
of HPV lesion surveillance.
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Figure 2. Correlation of pap test with cross-section of
cervix (mckinley.illinois.edu, 2016).

